Skip to main content

Table 1 eRNAs with confirmed functions in diseases

From: Enhancer RNAs: mechanisms in transcriptional regulation and functions in diseases

Diseases

eRNAs

Features

Functions

Ref

Cancer

NET1e

Enrichment of histone H3K4me1 and H3K27ac modification

NET1e contributes to breast cancer progression via upregulation of the important breast cancer oncogene NET1

[71]

HPSE eRNA

Consisting of three exons, non-polyadenylated

HPSE eRNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis

[72]

KLK3e

Bidirectional, sense (2,170 bp) and antisense (2,230 bp), some of them are polyadenylated

KLK3e facilitates the spatial interaction of the KLK3 enhancer and the KLK2 promoter, enhances long-distance KLK2 transcriptional activation

[92]

eRNAs produced from p53BERs

 ~ 600 nucleotides, Nonpolyadenylated

eRNAs produced from p53BERs are required for transcription enhancement of neighboring genes and an efficient p53-dependent cell-cycle arrest

[16]

PSA eRNA

Enrichment of H3K4me1, H3K4me2 and H3K27ac

The PSA eRNA binds to CYCLIN T1, activates P-TEFb and increases Pol II-Ser2p and cell growth

[69]

eNEMAL

762 nt, unspliced, polyadenylated

eNEMAL regulates the NEAT1 short/long isoform switch, promotes NEAT1 long isoform expression

[93]

 Inflammation

IL1β-eRNA

Unidirectional, with high H3K4me1/H3K4me3

Regulating the LPS-induced inflammatory response in human monocytes

[68]

 Neurological diseases

enh3256

-

Regulating GOLPH3L gene expression

[94]

 Myogenesis

CERNA, DRRRNA

DRRRNA: polyadenylated, single-stranded. CERNA: bidirectional, highly conserved in mammals

CERNA actives expression of MyoD in cis, DRRRNA activates the downstream myogenic genes in trans

[17]

DRReRNA

a ~ 2 Kb transcript, unidirectional, polyadenylated, spliced

DRReRNA directs Cohesin loading in trans to regulate Myogenin expression

[70]

  1. eRNAs enhancer RNAs, HPSE heparinase, KLK3 Kallikrein-related peptidase 3, p53BERs p53-bound enhancer regions, eNEMAL eRNA of the NEAT1-MALAT1-Locus, IL1β interleukin 1β, LPS lipopolysaccharide, CE core enhancer, DRR distal enhancers
  2. “-” means this part is not mentioned in the article